Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21041709rdf:typepubmed:Citationlld:pubmed
pubmed-article:21041709lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:21041709lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21041709lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:21041709lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:21041709lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:21041709lifeskim:mentionsumls-concept:C0441766lld:lifeskim
pubmed-article:21041709lifeskim:mentionsumls-concept:C0729296lld:lifeskim
pubmed-article:21041709lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:21041709pubmed:issue35lld:pubmed
pubmed-article:21041709pubmed:dateCreated2010-12-14lld:pubmed
pubmed-article:21041709pubmed:abstractTextStereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) is associated with high local control rates. The impact of introducing SBRT in patients 75 years of age or older was studied using a population-based cancer registry.lld:pubmed
pubmed-article:21041709pubmed:languageenglld:pubmed
pubmed-article:21041709pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21041709pubmed:citationSubsetIMlld:pubmed
pubmed-article:21041709pubmed:statusMEDLINElld:pubmed
pubmed-article:21041709pubmed:monthDeclld:pubmed
pubmed-article:21041709pubmed:issn1527-7755lld:pubmed
pubmed-article:21041709pubmed:authorpubmed-author:LagerwaardFra...lld:pubmed
pubmed-article:21041709pubmed:authorpubmed-author:SenanSureshSlld:pubmed
pubmed-article:21041709pubmed:authorpubmed-author:SlotmanBen...lld:pubmed
pubmed-article:21041709pubmed:authorpubmed-author:VisserOttoOlld:pubmed
pubmed-article:21041709pubmed:authorpubmed-author:BelderbosJose...lld:pubmed
pubmed-article:21041709pubmed:authorpubmed-author:PalmaDavidDlld:pubmed
pubmed-article:21041709pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21041709pubmed:day10lld:pubmed
pubmed-article:21041709pubmed:volume28lld:pubmed
pubmed-article:21041709pubmed:ownerNLMlld:pubmed
pubmed-article:21041709pubmed:authorsCompleteYlld:pubmed
pubmed-article:21041709pubmed:pagination5153-9lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:meshHeadingpubmed-meshheading:21041709...lld:pubmed
pubmed-article:21041709pubmed:year2010lld:pubmed
pubmed-article:21041709pubmed:articleTitleImpact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis.lld:pubmed
pubmed-article:21041709pubmed:affiliationLondon Regional Cancer Program, 790 Commissioners Rd E, London, Ontario, Canada N6A4L6. david.palma@uwo.calld:pubmed
pubmed-article:21041709pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21041709pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21041709lld:pubmed